Press Release

Vaccines Market: Global Industry Analysis by Top Manufacturers with Size, Share, Segments, Drivers and Challenges

Vaccines Market Share In-Depth Analysis of Industry Growth Trends & Forecast up to 2026

The global vaccines market size is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% during the forecast period. The growing prevalence of malaria around the world is a key factor boosting the vaccines market. According to the World Health Organization, in 2017, there were an estimated 219 million cases of malaria in 87 countries. Total funding for malaria control and elimination reached an estimated US$ 3.1 billion in 2017. Contributions from governments of endemic countries amounted to US$ 900 million, representing 28% of total funding. Furthermore, the increasing number of deaths caused by malaria has impelled government and pharmaceutical companies to develop advanced vaccines. According to the latest world malaria report, released in November 2018, there were 219 million cases of malaria in 2017, up from 217 million cases in 2016. The estimated number of malaria death stood at 435 000 in 2017, a similar number to the previous year.

Global Vaccines Market Segmentation

By Type

  • Recombinant/Conjugate/Subunit
  • Inactivated
  • Live Attenuated
  • Toxoid

By Route of Administration

  • Parenteral
  • Oral

By Disease Indication

  • Viral Diseases
  • Bacterial Diseases

By Age Group

  • Pediatric
  • Adults

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Some major points from Table of Content:

  1. Introduction

1.1.      Research Scope

1.2.      Market Segmentation

1.3.      Research Methodology

1.4.      Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.      Market Drivers

3.2.      Market Restraints

3.3.      Market Opportunities

  1. Key Insights

4.1.      New Product Launch

4.2.      Pipeline Analysis

4.3.      Technological Advancements in the Vaccines Market

4.4.      Prevalence of Disease Indications

4.5.      Key Industry Developments – Mergers, Acquisitions, and Partnerships

  1. Global Vaccines Market Analysis, Insights and Forecast, 2015-2026

5.1.      Key Findings / Summary

5.2.      Market Analysis, Insights and Forecast – By Type

5.2.1.   Recombinant/Conjugate/Subunit

5.2.2.   Inactivated

5.2.3.   Live Attenuated

5.2.4.   Toxoid

5.3.      Market Analysis, Insights and Forecast – By Route of Administration

5.3.1.   Parenteral

5.3.2.   Oral

5.4.      Market Analysis, Insights and Forecast – By Disease Indication

5.4.1.   Viral Diseases

5.4.2.   Bacterial Diseases

5.5.      Market Analysis, Insights and Forecast – By Age Group

5.5.1.   Pediatric

5.5.2.   Adults

5.6.      Market Analysis, Insights and Forecast – By Distribution Channel

5.6.1.   Hospital & Retail Pharmacies

5.6.2.   Government Suppliers

5.6.3.   Others

5.7.      Market Analysis, Insights and Forecast – By Geography

5.7.1.   North America

5.7.2.   Europe

5.7.3.   Asia pacific

5.7.4.   Latin America

5.7.5.   Middle East & Africa

  1. North America Vaccines Market Analysis, Insights and Forecast, 2015-2026

6.1.      Key Findings / Summary

6.2.      Market Analysis, Insights and Forecast – By Type

6.2.1.   Recombinant/Conjugate/Subunit

6.2.2.   Inactivated

6.2.3.   Live Attenuated

6.2.4.   Toxoid

6.3.      Market Analysis, Insights and Forecast – By Route of Administration

6.3.1.   Parenteral

6.3.2.   Oral

6.4.      Market Analysis, Insights and Forecast – By Disease Indication

6.4.1.   Viral Diseases

6.4.2.   Bacterial Diseases

6.5.      Market Analysis, Insights and Forecast – By Age Group

6.5.1.   Pediatric

6.5.2.   Adults

6.6.      Market Analysis, Insights and Forecast – By Distribution Channel

6.6.1.   Hospital & Retail Pharmacies

6.6.2.   Government Suppliers

6.6.3.   Others

6.7.      Market Analysis, Insights and Forecast – By Country

6.7.1.   U.S.

6.7.2.   Canada

  1. Europe Vaccines Market Analysis, Insights and Forecast, 2015-2026

7.1.      Key Findings / Summary

7.2.      Market Analysis, Insights and Forecast – By Type

7.2.1.   Recombinant/Conjugate/Subunit

7.2.2.   Inactivated

7.2.3.   Live Attenuated

7.2.4.   Toxoid

7.3.      Market Analysis, Insights and Forecast – By Route of Administration

7.3.1.   Parenteral

7.3.2.   Oral

7.4.      Market Analysis, Insights and Forecast – By Disease Indication

7.4.1.   Viral Diseases

7.4.2.   Bacterial Diseases

7.5.      Market Analysis, Insights and Forecast – By Age Group

7.5.1.   Pediatric

7.5.2.   Adults

7.6.      Market Analysis, Insights and Forecast – By Distribution Channel

7.6.1.   Hospital & Retail Pharmacies

7.6.2.   Government Suppliers

7.6.3.   Others

7.7.      Market Analysis, Insights and Forecast – By Country/Sub-region

7.7.1.   U.K.

7.7.2.   Germany

7.7.3.   France

7.7.4.   Spain

7.7.5.   Italy

7.7.6.   Scandinavia

7.7.7.   Rest of Europe

  1. Asia Pacific Vaccines Market Analysis, Insights and Forecast, 2015-2026

8.1.      Key Findings / Summary

8.2.      Market Analysis, Insights and Forecast – By Type

8.2.1.   Recombinant/Conjugate/Subunit

8.2.2.   Inactivated

8.2.3.   Live Attenuated

8.2.4.   Toxoid

8.3.      Market Analysis, Insights and Forecast – By Route of Administration

8.3.1.   Parenteral

8.3.2.   Oral

8.4.      Market Analysis, Insights and Forecast – By Disease Indication

8.4.1.   Viral Diseases

8.4.2.   Bacterial Diseases

8.5.      Market Analysis, Insights and Forecast – By Age Group

8.5.1.   Pediatric

8.5.2.   Adults

8.6.      Market Analysis, Insights and Forecast – By Distribution Channel

8.6.1.   Hospital & Retail Pharmacies

8.6.2.   Government Suppliers

8.6.3.   Others

8.7.      Market Analysis, Insights and Forecast – By Country/Sub-region

8.7.1.   Japan

8.7.2.   China

8.7.3.   India

8.7.4.   Australia

8.7.5.   Southeast Asia

8.7.6.   Rest of Asia Pacific

Continued…

More Trending Topics From Fortune Business [email protected]

What’s Driving the Wheelchair Market Growth? Prominent Players: Invacare Corporation, AliMed, Sunrise Medical, Seating Matters, Stryker, DeVilbiss Healthcare, Others

Why the Vaccines Market Is Set to Explode? Top Companies: GlaxoSmithKline Plc., Sanofi Pfizer Inc., Merck & Co., Inc., Novartis AG, Emergent BioSolutions, Inc., CSL Limit

Pet Insurance Market 2020, Focuses on Top Companies, Global Industry Analysis, Recent Trends and Regional Growth Forecast 2026

 

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close